Ani Pharmaceuticals, Inc
$1.63B- Market cap
- $1.60B
- Debt
- +$309.11M
- Cash
- −$285.59M
Capital structure 84% equity / 16% debt · EV / Revenue 1.84x · EV / EBITDA 7.53x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ANIP · current priceP/E 21.46x
$71.25Latest market snapshot
Implied fair value · at BUD's multiple
$77.348.5% above market
3.32 ANIP EPS (TTM)×23.30x BUD P/E=$77.34
Market $71.25Implied $77.34
BUD · current priceP/E 23.30x
$80.37Latest market snapshot
Implied fair value · at ANIP's multiple
$74.047.9% below market
3.45 BUD EPS (TTM)×21.46x ANIP P/E=$74.04
Market $80.37Implied $74.04